Advertisement

Topics

Search Results for "Metformin Hidradenitis"

18:45 EDT 25th September 2016 | BioPortfolio

Matching Channels

Matching News

U.S. FDA Approves INVOKAMET® XR (Canagliflozin / Metformin Hydrochloride Extended-Release) for ...

Phase 3 studies have shown the combination of INVOKANA ®and metformin reduces A1C significantly more than metformin alone, sitagliptin plus metformin, or glimepiride plus Read more...

Adalimumab for the Treatment of Hidradenitis Suppurativa

Hidradenitis suppurativa is a severe and chronic auto-inflammatory disease, with few therapeutic options, but recent Phase III clinical trials on the efficacy of adalimumab show promise. Skin Therap...

Humira Partially Effective Against Hidradenitis Suppurativa

The anti-inflammatory drug adalimumab can provide significant relief for about a quarter of people who suffer from a moderate-to-severe case of the chronic skin condition hidradenitis suppurativa, acc...

Excision, unroofing procedures effective surgical treatment of hidradenitis suppurativa

Excision and unroofing were effective surgical procedures for patients with hidradenitis suppurativa, with a low complication rate and moderate rate of postoperative recurrence, according to recently ...

Metformin in cancer prevention

Prof Pollack speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about the repurposing of metformin to treat cancer. Metformin is a widely used treatment for type II diabetes, but has also...

UK NICE recommends Humira as treatment for hidradenitis suppurativa

The National Institute for Health and Care Excellence (NICE) has recommended the use of biopharmaceutical company AbbVie's Humira (adalimumab) for treatment of hidradenitis suppurativa (HS) in adults.

Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin

Ewan Pearson, Kathleen Giacomini and the Metformin Genetics Consortium perform a genome-wide association study for glycemic response to the antidiabetic drug metformin. They find an intronic allele of...

Metformin Active in Reducing Colorectal Polyp Recurrence

Dr David Kerr reports on a randomized study in which low-dose metformin reduced recurrence of colorectal polyps from 56% to 38%. Is metformin potentially another strategy to prevent colorectal cancer?...

Matching PubMed Articles

Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.

Prevalence and predictors of metformin prescribing in adults with type 2 diabetes mellitus: a national cross sectional study.

Metformin is the first-line oral type 2 diabetes treatment. Despite an abundance of evidence, metformin is routinely under-utilized. This study evaluated the rates of metformin usage in an approp...

Metformin and the gastrointestinal tract.

Metformin is an effective agent with a good safety profile that is widely used as a first-line treatment for type 2 diabetes, yet its mechanisms of action and variability in terms of efficacy and side...

Involvement of Glucagon-like Peptide-1 in the Glucose-lowering effect of Metformin.

Metformin is an oral antihyperglycaemic drug used as first-line treatment of type 2 diabetes. Metformin's classical and most well-known blood glucose-lowering mechanisms include reduction of hepatic g...

The relationship between metformin and serum prostate-specific antigen levels.

Metformin is the first-line oral antihyperglycemic of choice for individuals with type 2 diabetes. Recent evidence supports a role for metformin in prostate cancer chemoprotection. However, whether me...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement